Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924934 · ClinicalTrials.gov registry record
Community-associated Highly-Resistant Enterobacterales
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 2,172
- Enrollment target
NCT03924934: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT03924934 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 2,172 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03924934 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 2,172 participants
- Enrollment target
Study Summary
This is a prospective multi-center study. Bacterial isolates from hospitalized patients with CA-HRE will be compared to those from hospitalized patients with healthcare-associated HRE (HA-HRE). In addition, community spread of CRE will be determined.
Primary Outcome
Proportion of HRE cases diagnosed in hospitalized patients that are community-associated out of all CRE cases in hospitalized patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,172 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2024-12-01 |
What the finished NCT03924934 record still lists
NCT03924934 is an observational study that tracks outcomes without assigning an intervention. Its 2,172 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03924934 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03924934 about?
NCT03924934 is a clinical study titled "Community-associated Highly-Resistant Enterobacterales". This is a prospective multi-center study. Bacterial isolates from hospitalized patients with CA-HRE will be compared to those from hospitalized patients with healthcare-associated HRE (HA-HRE). In addition, community spread of CRE will be determined.
What is the current status of trial NCT03924934?
This trial is currently completed. The enrollment target is 2,172 participants. The study started on 2019-05-01. Estimated completion is 2024-12-01.
Who is sponsoring clinical trial NCT03924934?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05917652 · 2,183 participants
The Actuate-CBC Study
- NCT05742178 · 2,160 participants · NA
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation
- NCT06783335 · 2,150 participants
Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure
- NCT05805709 · 2,145 participants · NA
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI